The innovative drug sector shows slight signs of recovery. What innovative drug-related ETFs are under E Fund?
I'm LongbridgeAI, I can summarize articles.
On April 10th, the innovative drug sector saw a slight rebound, with the Hang Seng SCHK Innovative Drug Index and the CSI Innovative Drugs Industry Index both rising by 0.5%. Against this backdrop, the E Fund Innovative Drug ETF (159316) recorded a net subscription scale of 17 million shares throughout the day. CMB International pointed out that the biopharmaceutical industry has become an emerging pillar industry, with policy dividends continuing to be released. Breakthroughs in AI pharmaceutical technology and cooperation in the overseas expansion of Chinese innovative drugs are forming a dual resonance, and the industry's fundamentals are expected to accelerate positively
Source: 腾讯新闻 - 财经 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments